Cellectis Q4 2023 GAAP EPS $(0.64) Misses $(0.26) Estimate, Sales $1.990M Miss $16.263M Estimate
Cellectis Q4 2023 GAAP EPS $(0.64) Misses $(0.26) Estimate, Sales $1.990M Miss $16.263M Estimate
Cellectis2023年第四季度GAAP每股收益（0.64美元）未達到預期（0.26美元），銷售額爲19.9億美元，未達到1626.3萬美元的預期
Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.26) by 146.15 percent. The company reported quarterly sales of $1.990 million which missed the analyst consensus estimate of $16.263 million by 87.76 percent. This is a 88.51 percent decrease over sales of $17.322 million the same period last year.
Cellectis（納斯達克股票代碼：CLLS）公佈的季度虧損爲每股0.64美元，比分析師普遍預期的0.26美元（0.26美元）低146.15個百分點。該公司公佈的季度銷售額爲19.9億美元，比分析師普遍預期的1626.3萬美元低87.76％。這比去年同期的1732.2萬美元的銷售額下降了88.51％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。